NEW YORK (Reuters Health) – A review of past research concludes that people taking Pfizer’s smoking-cessation drug Chantix do not have a higher risk of heart attacks and other serious heart problems as was reported by a study last year.
Popular Posts:
- HEART DISEASE AWARENESS MILLION DOLLAR NOVELTY BILL – Lot of 10 BILLS
- 1 in 4 Americans without health coverage, study finds
- 1 in 4 Americans without health coverage, study finds
- 1 in 4 Americans without health coverage, study finds
- Contessa One Heart Beats: Know the TRUTH about the Government …